Chapter 947 Hitting Bottom
“Currently, China has announced penalties against GlaxoSmithKline and issued them a fine of 3 billion Chinese dollars. This is also the highest amount China has ever issued against a company. The ticket..."
Daisy elegantly pushed down her gold-rimmed glasses and continued:< br>
“As this result came out, GlaxoSmithKline’s stock price continued to fall after the opening, and it has already dropped nearly 5%.”
“We can take advantage of this opportunity. Closed the position and bought part of GSK (GlaxoSmithKline) shares. ”
"I think so too, and we have already started buying."
Although the 3 billion yuan fine issued by China to GlaxoSmithKline seems to be a lot.
But you must know that last year, in 2012, GlaxoSmithKline also paid 3 billion to reach a settlement with the U.S. drug regulatory authorities on fraud and other charges...but it was only US dollars!
This is also the largest settlement in history to date.
The U.S. Department of Justice said at the time that GlaxoSmithKline pleaded guilty to three criminal charges and was suspected of bribing doctors in the United States with luxury trips to Hawaii and academic lecture tours worth millions of dollars to prescribe medications to patients. Prescriptions for the company's products.
Andrew Witty, CEO of GlaxoSmithKline at the time, said afterwards, "We have learned from our mistakes."
Well, it seems from what happened in China that GlaxoSmithKline still didn’t learn thoroughly enough.
But for now, China’s “boot landing” also means that the biggest bad news for GlaxoSmithKline in these events has been determined-although it will inevitably affect Glaxo’s history again Gram's stock price, but after that, there is a possibility of bottoming out.
This is why both Barron and Daisy believe that they can close their short positions on GlaxoSmithKline's stock price and use the profits to continue to absorb its shares.
The current market value of GlaxoSmithKline has dropped from last year’s high of more than 120 billion US dollars to less than 80 billion US dollars.
According to calculations, DS Group’s short-selling operation against GlaxoSmithKline’s stock price will ultimately make a profit of approximately US$8 billion.
This means that if these profits are invested in acquiring its shares, nearly 10% of GlaxoSmithKline's shares can be obtained.
But in reality, this is not how it is calculated.
Although the market value of GlaxoSmithKline is now less than 80 billion U.S. dollars, as they liquidate their positions and subsequently absorb GlaxoSmithKline stocks, with the amount of tens of billions of funds involved, of course they cannot What is avoided will rise significantly.
So even if all the profits of 8 billion US dollars are invested, according to estimates, you can get about 8-8.5% of the shares. The specific proportion depends on the market conditions.
As for buying GlaxoSmithKline shares from some institutions?
Of course this is possible, but it is certainly impossible to buy at the current price - those institutions will not cut off the flesh so happily, since Daisy can see that GlaxoSmithKline's stock price may bottom out. , it is naturally impossible for those institutions not to be able to see it.
DS Group was able to successfully short GlaxoSmithKline's stock price. The difference is that before this "emergency" event, they had already established a position to ambush...
If things change, Didn’t the GlaxoSmithKline bribery incident in China happen on time like it did in the original time and space?
Such a large-scale short selling has already been planned. If this incident did not happen, Barron's side would not hesitate to send people directly to report it to China...
After all, with the current amount of funds invested by DS Group, it is very rare to be able to carry out this kind of operation against a company, and it is only possible for large companies with a market value of more than 100 billion. It's a rare opportunity, so it's impossible to miss it.
……
On September 20, Hangyu Seiko officially released the latest drone in the Hummingbird series, the HUM-2 drone.
This is also the third Hummingbird series drone launched by Hangyu Seiko - they launched HUM-1 and HUM-1Pro respectively last year and early this year, two Hummingbird series drones, both of which won the Got a good response.
In particular, the HUM-1Pro has upgraded the performance of the first-generation HUM-1 drone, and optimized the controllability and flight posture, but the price is only 1999 euros, the same as the HUM-1. This has also increased the sales of HUM-1Pro.
However, compared with the previous two Hummingbird drones, the launch of HUM-2 is disruptive.
Not only has HUM-2 continued to improve its performance, but also, like the Phantom series drones launched by its competitor DJI, this time it comes with a high-definition lens, which can be said to be more cost-effective has been greatly improved.
Thanks to the fact that Hangyu Precision has established an advanced "robot production workshop" in Birmingham, and most of its accessories have obtained long-term partners in China, its cost control has made great progress.
Of course, this is also related to the fact that after the first two Hummingbird series drones, Hangyu Precision has gained scale advantages in the supply chain and reduced procurement costs.
In the end, the price of HUM-2 was directly reduced to 1,599 euros on the premise that its performance was greatly improved, allowing it to compete with DJI's Phantom series drones.
Therefore, on the day when Hangyu Seiko’s HUM-2 drone went on sale, users lined up to buy it at the entrances of Hangyu Seiko experience stores in London and New York.
As mentioned before, the HUM (Hummingbird) series is Hangyu Seiko’s entry-level drone product model for families and non-professional groups. It focuses on easy operation and portability.
In addition, Hangyu Seiko also launched the G1, the first product of the Griffin series of drones, at the end of last year.
The G1 is larger and can carry professional camera equipment, so it is popular with professional photographers.
After all, before this, if aerial photography was needed, it was often necessary to use a helicopter or a hot air balloon, which was not only expensive but also had its own limitations.
However, the emergence of DJI’s Hot Wheels and Aerospace Seiko G1 has made aerial photography a more convenient choice for large film and television crews and small travel shooting teams.
The second product of the Hangyu Seiko Griffin series, G2, will also be launched around Christmas. For this reason, they will also build a new "robot" at the Hangyu Seiko manufacturing base in Birmingham. "Production Line"...
At present, the two most important rotor unmanned products of Hangyu Seiko are the Hummingbird series and the Lion and Heron series. In the future, they will maintain the rhythm of launching 1-2 new products each year.
To this end, Hangyu Precision has continued to expand the scale of their R&D center in London, recruiting more technicians and professionals to reserve technology and talents.
There is no doubt that after the launch of the HUM-2 drone, Barron's children will get their new toys...
(End of this chapter)